Hisamitsu Pharmaceutical ... (HTSUF)

PNK: HTSUF · Real-Time Price · USD

32.30

0.00 (0.00%)

At close: Apr 28, 2025, 9:30 AM

Hisamitsu Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is March - February.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020	Feb 28, 2019	Feb 28, 2018	Feb 28, 2017	Feb 29, 2016
Cash & Equivalents	112.46B	122.15B	129.29B	114.25B	107.05B	110.28B	117.19B	80.28B	81.58B
Short-Term Investments	12.86B	14.71B	13.14B	21.74B	34.88B	20.95B	14.76B	32.77B	30.89B
Long-Term Investments	76.81B	46.13B	39.38B	32.86B	13.5B	33.27B	42.62B	17.42B	17.47B
Other Long-Term Assets	1.65B	23.11B	21.75B	29.36B	43.29B	28.74B	22.71B	39.78B	37.3B
Receivables	42.98B	39.75B	38.11B	39.2B	48.91B	39.66B	34.95B	35.77B	37.35B
Inventory	21.18B	18.92B	16.41B	18.57B	15.46B	15.76B	16.97B	17.69B	15.91B
Other Current Assets	4.54B	3.63B	3.22B	4.29B	2.96B	6.92B	6.2B	5.59B	6.01B
Total Current Assets	194.02B	199.17B	200.18B	198.06B	209.25B	193.57B	190.06B	172.1B	171.76B
Property-Plant & Equipment	49.46B	43.21B	39.07B	37.35B	38.6B	39.56B	40.06B	43.03B	43.85B
Goodwill & Intangibles	6.83B	945M	1.32B	1.18B	1.47B	1.99B	4.1B	5.97B	12.52B
Total Long-Term Assets	134.75B	114.74B	102.68B	101.8B	98.15B	103.94B	109.84B	106.72B	113.19B
Total Assets	328.78B	313.92B	302.86B	299.86B	307.4B	297.51B	299.91B	278.82B	284.95B
Account Payables	9.61B	14.92B	13.22B	14.8B	19.02B	14.15B	13.91B	14.38B	14.02B
Deferred Revenue	4.54B	15.85B	11.12B	8.7B	15.29B	8.53B	13.95B	10.66B	15.29B
Short-Term Debt	1.07B	1.07B	1.07B	1.11B	1.21B	1.36B	1.46B	1.56B	1.68B
Other Current Liabilities	21.88B	24.92B	16.2B	12.7B	19.2B	13.18B	17.86B	14.75B	23.32B
Total Current Liabilities	45.94B	42.58B	32.16B	30.06B	41.05B	30.35B	34.94B	32.42B	41B
Long-Term Debt	76M	147M	219M	296M	368M	433M	504M	576M	647M
Other Long-Term Liabilities	15.09B	1.82B	2.34B	2.56B	4.53B	3.62B	4.06B	4.03B	10.36B
Total Long-Term Liabilities	15.77B	12.94B	15.82B	16B	15.61B	19B	19.75B	17.19B	17.86B
Total Liabilities	61.7B	55.51B	47.98B	46.06B	56.66B	49.35B	54.69B	49.62B	58.86B
Total Debt	2.1B	2.29B	2.46B	1.6B	1.77B	1.89B	2.06B	2.19B	2.4B
Common Stock	8.47B	8.47B	8.47B	8.47B	8.47B	8.47B	8.47B	8.47B	8.47B
Retained Earnings	242.58B	235.57B	236.19B	233.38B	230.93B	248.69B	236.34B	224.21B	210.72B
Comprehensive Income	n/a	37.16B	25.67B	19.59B	19.33B	24.68B	27.98B	24.21B	23.53B
Shareholders Equity	264.87B	256.36B	253.16B	252.29B	249.27B	246.86B	244B	228.1B	225.09B
Total Investments	67.12B	60.84B	52.52B	54.6B	48.38B	54.21B	57.38B	50.19B	48.36B